ANALISIS FAKTOR PENYEBAB MELONJAKNYA ANGGARAN OBAT PEMERINTAH KOTA BATAM SETELAH PEMBEBASAN BIAYA RETRIBUSI PASIEN PUSKESMAS

Abstract

Background: Batam municipal government has implemented
the program of patient retribution cost exemption in all health
centers of Batam Municipality with no exception (includes the
haves and the have not) as long as they can show their
population identity card when they visit health canters.
Consequently health budget increases four times higher than
the previous fiscal year. This is interesting to study further in
order to find out the effectiveness or ineffectiveness of the
program implementation.
Objective: The study aimed to analyze the policy of retribution
exemption and increased drug expenditure budget.
Method: The study was retrospective observational using
both quantitative and qualitative data, analytical survey method
and cross sectional design. Quantitative data were obtained
with cluster sampling from documents of health centers such
as monthly report, number of visits of the patients, prescription
within three years (2005 – 2007) of samples of each year
were taken three months during peak visits to health centers
(June, July and August). Data obtained were tabulated and
analyzed using paired t-test at significance level 95%.
Qualitative data were obtained from in-depth interview with
related stakeholders.
Result: Retribution exemption program led to sharp increase
of visits to health centers to twice. There was no difference in
disease pattern before and after retribution exemption. The
result of paired t-test to prescription pattern showed difference
before and after retribution exemption. The Health Institution of
Batam succeeded to maintain good prescription pattern.
Conclusion  : Caused sharp increase of drug budget after
retribution exemption in health centers was over anticipate of
drug procurement to forecast of visits health centre. The over
procurement can be anticipated by planning of drug
procurement the next years.
Keywords: health centers, retribution exemption, drug budget